glp-1 obesity drug news october 21 2025 Americans Need More Information About Weight Loss Drugs Study finds 40% of GLP-1

Description

2025;48(1 Suppl 1):S181206

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society

Additionally, factors secreted by retinal cells, like IL-6, promote the proliferation of different retinal cell types, contributing to the formation of new blood vessels and the progression of diabetic retinopathy (84)

Promotional structures vary, and clarity matters

FDA-approved options like semaglutide and tirzepatide have strong safety profiles, but a healthcare provider must determine which is most appropriate for your body